Skip to main content

Table 4 Main clinical characteristics of patients group according to ApoA1 and CRP levels

From: A novel score based on serum apolipoprotein A-1 and C-reactive protein is a prognostic biomarker in hepatocellular carcinoma patients

Variables ApoA1(g/L)   CRP  
Median (Range) p-Value Median(Range) p-Value
Gender
 Male 1.10(0.15–1.80) 0.236 3.685(0.16–251.70) 0.083
 Female 1.09(0.56–1.72)   2.60(0.10–92.96)  
Age (years)
  < 53 1.095(0.23–1.80) 0.539 4.08(0.16–210.65) 0.064
  ≥ 53 1.10(0.15–1.72)   2.89(0.10–251.70)  
TNM stage
 I-II 1.13(0.15–1.80) < 0.001 2.255(0.10–241.15) < 0.001
 III-IV 1.03(0.16–1.64)   9.61(0.24–251.70)  
Tumor size(cm)
  < 5 1.13(0.15–1.80) < 0.001 2.35(0.10–241.25) < 0.001
  ≥ 5 1.03(0.16–1.64)   9.66(0.24–251.70)  
Tumor number
 Single 1.10(0.15–1.80) 0.544 2.73(0.10–251.70) 0.001
 Multiple 1.10(0.41–1.64)   5.60(0.24–132.49)  
Node stage
 N0 1.10(0.15–1.80) 0.059 3.425(0.10–251.70) 0.005
 N1–2 1.01(0.35–1.48)   8.03(0.57–194.10)  
Distant metastases
 No 1.10(0.15–1.80) 0.169 3.49(0.10–251.70) 0.008
 Yes 1.04(0.16–1.56)   9.66(0.60–92.96)  
BMI (kg/m2)
  ≥ 24.0 1.085(0.30–1.72) 0.756 2.89(0.16–241.25) 0.264
 18.5–23.9 1.11(0.15–1.80)   4.03(0.10–251.70)  
  < 18.5 1.08(0.41–1.77)   4.75(0.25–146.40)  
Alcohol behavior
 Never 1.10(0.15–1.80) 0.802 3.59(0.10–194.10) 0.409
 Previous/Current 1.08(0.16–1.65)   3.56(0.16–251.70)  
Family history of cancer
 No 1.10(0.15–1.80) 0.772 3.56(0.10–251.70) 0.403
 Yes 1.10(0.16–1.77)   3.765(0.30–126.24)  
HBs Ag
 Negative 1.10(0.15–1.80) 0.664 3.28(0.23–251.70) 0.780
 Positive 1.10(0.15–1.80)   3.56(0.10–210.65)  
HBe Ag
 Negative 1.07(0.15–1.80) 0.492 3.71(0.16–251.70) 0.754
 Positive 1.12(0.16–1.52)   3.79(0.25–130.04)  
HCV Ab
 Negative 1.10(0.15–1.80) 0.197 3.64(0.10–251.70) 0.075
 Positive 1.02(0.26–1.64)   1.88(0.23–194.10)  
AFP (ng/mL)
  < 400 1.11(0.16–1.80) 0.020 3.10(0.10–251.70) < 0.001
  ≥ 400 1.04(0.15–1.58)   8.20(0.30–241.25)